Fisher scientific award lecture - the capsular polysaccharides of group b streptococcus and streptococcus suis differently modulate bacterial interactions with dendritic cells

Canadian Journal of Microbiology

Volumn 58, Issue 3, 2012, Pages 249-260

  Segura, Mariela ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Capsular polysaccharide; Dendritic cells; Endocytosis; Lipid rafts; Sialic acid; Streptococcus

Indexed keywords

BACTERIAL POLYSACCHARIDE; SIALIC ACID;

ADAPTATION; BACTERIUM; COMMUNITY COMPOSITION; ENCAPSULATION; GENE EXPRESSION; HOST-PATHOGEN INTERACTION; IMMUNE RESPONSE; LIPID; MOLECULAR ANALYSIS; POLYSACCHARIDE; PROTEIN; VIRULENCE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; BACTERIAL VIRULENCE; CARBOHYDRATE ANALYSIS; DENDRITIC CELL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; ZOONOSIS;

ANIMALS; BACTERIAL CAPSULES; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SUIS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS SP. 'GROUP B'; STREPTOCOCCUS SUIS; SUIDAE;

EID: 84857848875     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/W2012-003     Document Type: Review

References (103)

1. Albanyan, E.A., and Edwards, M.S. 2000. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci. Infect. Immun. 68(10): 5794-5802. doi:10.1128/IAI.68.10.5794-5802.2000. PMID:10992487.
2. Alvarez, D., Vollmann, E.H., and von Andrian, U.H. 2008. Mechanisms and consequences of dendritic cell migration. Immunity, 29(3): 325-342. doi:10.1016/j.immuni.2008.08.006. PMID:18799141.
3. Aoyagi, Y., Adderson, E.E., Min, J.G., Matsushita, M., Fujita, T., Takahashi, S., et al. 2005. Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J. Immunol. 174(1): 418-425. PMID:15611266.
4. Areschoug, T., Waldemarsson, J., and Gordon, S. 2008. Evasion of macrophage scavenger receptor A-mediated recognition by pathogenic streptococci. Eur. J. Immunol. 38(11): 3068-3079.doi:10.1002/eji.200838457. PMID:18924218.
5. Benga, L., Fulde, M., Neis, C., Goethe, R., and Valentin-Weigand, P. 2008. Polysaccharide capsule and suilysin contribute to extracellular survival of Streptococcus suis co-cultivated with primary porcine phagocytes. Vet. Microbiol. 132(1-2): 211-219. doi:10. 1016/j.vetmic.2008.05.005. PMID:18565698.
6. Bonazzi, M., and Cossart, P. 2006. Bacterial entry into cells: a role for the endocytic machinery. FEBS Lett. 580(12): 2962-2967. doi:10. 1016/j.febslet.2006.04.010. PMID:16650411.
7. Burgdorf, S., Kautz, A., Bohnert, V., Knolle, P.A., and Kurts, C. 2007. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science, 316(5824): 612-616. doi:10.1126/science.1137971. PMID:17463291.
8. Carlin, A.F., Lewis, A.L., Varki, A., and Nizet, V. 2007. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin- like lectins) on human leukocytes. J. Bacteriol. 189(4): 1231-1237. doi:10.1128/JB.01155-06. PMID:16997964.
9. Carlin, A.F., Uchiyama, S., Chang, Y.C., Lewis, A.L., Nizet, V., and Varki, A. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood, 113(14): 3333-3336. doi:10.1182/blood-2008-11-187302. PMID:19196661.
10. Chabot-Roy, G., Willson, P., Segura, M., Lacouture, S., and Gottschalk, M. 2006. Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb. Pathog. 41(1): 21-32. doi:10. 1016/j.micpath.2006.04.001. PMID:16714092.
11. Chaffin, D.O., Mentele, L.M., and Rubens, C.E. 2005. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J. Bacteriol. 187(13): 4615-4626. doi:10.1128/JB.187. 13.4615-4626.2005. PMID:15968073.
12. Charland, N., Kobisch, M., Martineau-Doizé, B., Jacques, M., andGottschalk, M. 1996. Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2. FEMS Immunol. Med. Microbiol. 14(4): 195-203. doi:10.1111/j. 1574-695X.1996.tb00287.x. PMID:8856318.
13. Charland, N., Harel, J., Kobisch, M., Lacasse, S., and Gottschalk, M. 1998. Streptococcus suis serotype 2 mutants deficient in capsular expression. Microbiology, 144(2): 325-332. doi:10.1099/ 00221287-144-2-325. PMID:9493370.
14. Chattopadhyay, D., Carey, A.J., Caliot, E., Webb, R.I., Layton, J.R., Wang, Y., et al. 2011. Phylogenetic lineage and pilus protein Spb1/ SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus. Microbes Infect. 13(4): 369-382. doi:10.1016/j.micinf.2010.12.009. PMID:21238599.
15. Cieslewicz, M.J., Chaffin, D., Glusman, G., Kasper, D., Madan, A., Rodrigues, S., et al. 2005. Structural and genetic diversity of group B Streptococcus capsular polysaccharides. Infect. Immun. 73(5): 3096-3103. doi:10.1128/IAI.73.5.3096-3103.2005. PMID:15845517.
16. Corbett, D., and Roberts, I.S. 2009. The role of microbial polysaccharides in host-pathogen interaction. F1000 Biol. Rep. 1: 30. doi:10.3410/B1-30.
17. Cornacchione, P., Scaringi, L., Fettucciari, K., Rosati, E., Sabatini, R., Orefici, G., et al. 1998. Group B streptococci persist inside macrophages. Immunology, 93(1): 86-95. doi:10.1046/j.1365- 2567.1998.00402.x. PMID:9536123.
18. Crocker, P.R., Paulson, J.C., and Varki, A. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7(4): 255-266. doi:10.1038/nri2056. PMID:17380156.
19. Domínguez-Punaro, M.C., Segura, M., Contreras, I., Lachance, C., Houde, M., Lecours, M.-P., et al. 2010. In vitro characterization of the microglial inflammatory response to Streptococcus suis, an important emerging zoonotic agent of meningitis. Infect. Immun. 78(12): 5074-5085. doi:10.1128/IAI.00698-10. PMID:20876287.
20. Draper, D.W., Bethea, H.N., and He, Y.W. 2006. Toll-like receptor 2- dependent and -independent activation of macrophages by group B streptococci. Immunol. Lett. 102(2): 202-214. doi:10.1016/j.imlet. 2005.09.005. PMID:16242782.
21. Duncan, M.J., Shin, J.S., and Abraham, S.N. 2002. Microbial entry through caveolae: variations on a theme. Cell. Microbiol. 4(12): 783-791. doi:10.1046/j.1462-5822.2002.00230.x. PMID: 12464009.
22. Edwards, M.S. 2008. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum. Vaccin. 4(6): 444-448. doi:10.4161/hv.4.6.6507. PMID:18728401.
23. Edwards, M.S., and Baker, C.J. 2005. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41(6): 839-847. doi:10.1086/432804. PMID:16107984.
24. Edwards, M.S., Nicholson-Weller, A., Baker, C.J., and Kasper, D.L. 1980. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J. Exp. Med. 151(5): 1275-1287. doi:10.1084/ jem.151.5.1275. PMID:6989947.
25. Edwards, M.S., Kasper, D.L., Jennings, H.J., Baker, C.J., and Nicholson-Weller, A. 1982. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J. Immunol. 128(3): 1278-1283. PMID:7035562.
26. Edwards, M.S., Wessels, M.R., and Baker, C.J. 1993. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. Infect. Immun. 61(7): 2866-2871. PMID:8514389.
27. Fan, H., Williams, D.L., Zingarelli, B., Breuel, K.F., Teti, G., Tempel, G.E., et al. 2007. Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in macrophages by Gai proteins. Immunology, 122(1): 116-123. doi:10.1111/j.1365-2567.2007.02619.x. PMID:17484771.
28. Gottschalk, M., and Segura, M. 2000. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76(3): 259-272. doi:10.1016/S0378-1135(00) 00250-9. PMID:10973700.
29. Gottschalk, M., Segura, M., and Xu, J. 2007. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health Res. Rev. 8(1): 29-45. doi:10.1017/ S1466252307001247. PMID:17692141.
30. Gottschalk, M., Xu, J., Calzas, C., and Segura, M. 2010. Streptococcus suis: A new emerging or an old neglected zoonotic pathogen? Future Microbiol. 5(3): 371-391. doi:10.2217/fmb.10. 2. PMID:20210549.
31. Graveline, R., Segura, M., Radzioch, D., and Gottschalk, M. 2007. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int. Immunol. 19(4): 375-389. doi:10.1093/intimm/dxm003. PMID:17307800.
32. Guttormsen, H.K., Paoletti, L.C., Mansfield, K.G., Jachymek, W., Jennings, H.J., and Kasper, D.L. 2008. Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to- IgG switching. Proc. Natl. Acad. Sci. U.S.A. 105(15): 5903-5908. doi:10.1073/pnas.0710799105. PMID:18378894.
33. Haft, R.F., Wessels, M.R., Mebane, M.F., Conaty, N., and Rubens, C. E. 1996. Characterization of cpsF and its product CMP-Nacetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol. Microbiol. 19(3): 555-563. doi:10.1046/j. 1365-2958.1996.395931.x. PMID:8830246.
34. Harris, T.O., Shelver, D.W., Bohnsack, J.F., and Rubens, C.E. 2003. A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J. Clin. Invest. 111(1): 61-70. PMID:12511589.
35. He, Y.W., Li, H., Zhang, J., Hsu, C.L., Lin, E., Zhang, N., et al. 2004. The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat. Immunol. 5(1): 88-97. doi:10.1038/ni1021. PMID:14691481.
36. Henneke, P., Takeuchi, O., Malley, R., Lien, E., Ingalls, R.R., Freeman, M.W., et al. 2002. Cellular activation, phagocytosis, and bactericidal activity against group B Streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J. Immunol. 169(7): 3970-3977. PMID: 12244198.
37. Houde, M., Gottschalk, M., Gagnon, F., Van Calsteren, M.R., and Segura, M. 2012. Streptococcus suis capsular polysaccharide inhibits phagocytosis through destabilization of lipid microdomains and prevents lactosylceramide-dependent recognition. Infect. Immun. 80(2): 506-517. doi:10.1128/IAI.05734-11. PMID:22124659.
38. Hunter, C.A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5(7): 521-531. doi:10.1038/nri1648. PMID:15999093.
39. Jacobs, R.F., Kiel, D.P., Sanders, M.L., and Steele, R.W. 1985. Phagocytosis of type III group B streptococci by neonatal monocytes: enhancement by fibronectin and gammaglobulin. J. Infect. Dis. 152(4): 695-700. doi:10.1093/infdis/152.4.695. PMID:2413135.
40. Kelly-Scumpia, K.M., Scumpia, P.O., Delano, M.J., Weinstein, J.S., Cuenca, A.G., Wynn, J.L., and Moldawer, L.L. 2010. Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J. Exp. Med. 207(2): 319-326. doi:10.1084/jem.20091959. PMID: 20071504.
41. Klein Klouwenberg, P., and Bont, L. 2008. Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines. Clin. Dev. Immunol. 2008. doi:10.1155/2008/628963. PMID:18825269.
42. Koenig, J.M., and Keenan, W.J. 2009. Group B Streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr. Clin. North Am. 56(3): 689-708. doi:10.1016/j.pcl.2009.04.003. PMID: 19501699.
43. La Pine, T.R., Joyner, J.L., Augustine, N.H., Kwak, S.D., and Hill, H. R. 2003. Defective production of IL-18 and IL-12 by cord blood mononuclear cells influences the T helper-1 interferon gamma response to group B streptococci. Pediatr. Res. 54(2): 276-281. doi:10.1203/01.PDR.0000072515.10652.87. PMID:12736393.
44. Lecours, M.P., Gottschalk, M., Houde, M., Lemire, P., Fittipaldi, N., and Segura, M. 2011a. Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J. Infect. Dis. 204(6): 919-929. doi:10. 1093/infdis/jir415. PMID:21849289.
45. Lecours, M.P., Segura, M., Lachance, C., Mussa, T., Surprenant, C., Montoya, M., and Gottschalk, M. 2011b. Characterization of porcine dendritic cell response to Streptococcus suis. Vet. Res. 42 (1): 72. doi:10.1186/1297-9716-42-72. PMID:21635729.
46. Lewis, A.L., Nizet, V., and Varki, A. 2004. Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc. Natl. Acad. Sci. U.S.A. 101(30): 11123-11128. doi:10.1073/pnas.0403010101. PMID:15263085.
47. Lewis, A.L., Hensler, M.E., Varki, A., and Nizet, V. 2006. The group B streptococcal sialic acid O-acetyltransferase is encoded by neuD, a conserved component of bacterial sialic acid biosynthetic gene clusters. J. Biol. Chem. 281(16): 11186-11192. doi:10.1074/jbc. M513772200. PMID:16490781.
48. Lewis, A.L., Cao, H., Patel, S.K., Diaz, S., Ryan, W., Carlin, A.F., et al. 2007. NeuA sialic acid O-acetylesterase activity modulates Oacetylation of capsular polysaccharide in group B Streptococcus. J. Biol. Chem. 282(38): 27562 -27571.doi:10.1074/jbc.M700340200. PMID:17646166.
49. Maisey, H.C., Doran, K.S., and Nizet, V. 2008. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev. Mol. Med. 10: e27. doi:10.1017/ S1462399408000811. PMID:18803886.
50. Malisan, F., Franchi, L., Tomassini, B., Ventura, N., Condo, I., Rippo, M.R., et al. 2002. Acetylation suppresses the proapoptotic activity of GD3 ganglioside. J. Exp. Med. 196(12): 1535-1541. doi:10. 1084/jem.20020960. PMID:12486096.
51. Mancuso, G., Cusumano, V., Genovese, F., Gambuzza, M., Beninati, C., and Teti, G. 1997. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect. Immun. 65 (9): 3731-3735. PMID:9284145.
52. Mancuso, G., Gambuzza, M., Midiri, A., Biondo, C., Papasergi, S., Akiri, S., Teti, G., and Beninati, C. 2009. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10(6): 587-594. PMID:19430477.
53. Mañes, S., del Real, G., and Martínez-A, A.C. 2003. Pathogens: raft hijackers. Nat. Rev. Immunol. 3(7): 557-568. doi:10.1038/ nri1129. PMID:12876558.
54. Marques, M.B., Kasper, D.L., Pangburn, M.K., and Wessels, M.R. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60(10): 3986-3993. PMID:1398910.
55. Maruvada, R., Blom, A.M., and Prasadarao, N.V. 2008. Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology, 124 (2): 265-276. doi:10.1111/j.1365-2567.2007.02764.x. PMID: 18028369.
56. Maruvada, R., Prasadarao, N.V., and Rubens, C.E. 2009. Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J. 23(11): 3967-3977. doi:10.1096/fj.09-138149. PMID:19608625.
57. Melin, P. 2011. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin. Microbiol. Infect. 17 (9): 1294-1303.PMID:21672083.
58. Mond, J.J., Lees, A., and Snapper, C.M. 1995. T cell-independentantigens type 2. Annu. Rev. Immunol. 13(1): 655-692. doi:10. 1146/annurev.iy.13.040195.003255. PMID:7612238.
59. Monteiro, G.C., Hirata, R., Jr, Andrade, A.F., Mattos-Guaraldi, A.L., and Nagao, P.E. 2004. Surface carbohydrates as recognition determinants in non-opsonic interactions and intracellular viability of group B Streptococcus strains in murine macrophages. Int. J. Mol. Med. 13(1): 175-180. PMID:14654991.
60. Nagl, M., Kacani, L., Mullauer, B., Lemberger, E.M., Stoiber, H., Sprinzl, G.M., et al. 2002. Phagocytosis and killing of bacteria by professional phagocytes and dendritic cells. Clin. Diagn. Lab. Immunol. 9(6): 1165-1168. PMID:12414745.
61. Nakayama, H., Yoshizaki, F., Prinetti, A., Sonnino, S., Mauri, L., Takamori, K., et al. 2008. Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms. J. Leukoc. Biol. 83(3): 728-741. doi:10.1189/jlb.0707478. PMID:18055569.
62. Netea, M.G., Gijzen, K., Coolen, N., Verschueren, I., Figdor, C., Van der Meer, J.W., et al. 2004. Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. Microbes Infect. 6(11): 985-989. doi:10.1016/j.micinf.2004.05. 013. PMID:15345229.
63. Noel, G.J., Katz, S.L., and Edelson, P.J. 1991. The role of C3 in mediating binding and ingestion of group B Streptococcus serotype III by murine macrophages. Pediatr. Res. 30(1): 118-123. PMID:1891276.
64. Pierno, M., Maravigna, L., Piazza, R., Visai, L., and Speziale, P. 2006. FbsA-driven fibrinogen polymerization: a bacterial "deceiving strategy". Phys. Rev. Lett. 96(2): 028108. doi:10.1103/ PhysRevLett.96.028108. PMID:16486653.
65. Platt, M.W., Correa, N., Jr, and Mold, C. 1994. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway. Can. J. Microbiol. 40(2): 99-105. doi:10.1139/m94-016. PMID:8019940.
66. Poyart, C., Pellegrini, E., Gaillot, O., Boumaila, C., Baptista, M., and Trieu-Cuot, P. 2001. Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect. Immun. 69(8): 5098-5106. doi:10.1128/IAI.69.8.5098-5106.2001. PMID:11447191.
67. Poyart, C., Pellegrini, E., Marceau, M., Baptista, M., Jaubert, F., Lamy, M.C., and Trieu-Cuot, P. 2003. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 49(6): 1615-1625. doi:10.1046/j.1365- 2958.2003.03655.x. PMID:12950925.
68. Schubert, A., Zakikhany, K., Schreiner, M., Frank, R., Spellerberg, B., Eikmanns, B.J., and Reinscheid, D.J. 2002. A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mol. Microbiol. 46 (2): 557-569. doi:10.1046/j.1365-2958.2002.03177.x. PMID: 12406229.
69. Segura, M. 2009. Streptococcus suis: an emerging human threat. J. Infect. Dis. 199(1): 4-6. doi:10.1086/594371. PMID:19016626.
70. Segura, M., and Gottschalk, M. 2002. Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity. Infect. Immun. 70(8): 4312-4322. doi:10.1128/IAI. 70.8.4312-4322.2002. PMID:12117940.
71. Segura, M.A., Cléroux, P., and Gottschalk, M. 1998. Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages. FEMS Immunol. Med. Microbiol. 21(3): 189-195. doi:10.1111/j.1574-695X.1998.tb01165.x. PMID:9718208.
72. Segura, M., Stankova, J., and Gottschalk, M. 1999. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect. Immun. 67(9): 4646-4654. PMID:10456911.
73. Segura, M., Vadeboncoeur, N., and Gottschalk, M. 2002. CD14- dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin. Exp. Immunol. 127(2): 243-254. doi:10.1046/j.1365-2249.2002.01768.x. PMID:11876746.
74. Segura, M., Gottschalk, M., and Olivier, M. 2004. Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis. Infect. Immun. 72(9): 5322-5330. doi:10.1128/IAI.72.9.5322-5330.2004. PMID:15322029.
75. Segura, M., Vanier, G., Al-Numani, D., Lacouture, S., Olivier, M., and Gottschalk, M. 2006. Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol. Med. Microbiol. 47(1): 92-106. doi:10. 1111/j.1574-695X.2006.00067.x. PMID:16706792.
76. Segura, M., Calzas, C., Lemire, P., Lecours, M.P., Fittipaldi, N., Goyette Desjardins, G., et al. 2011. Comparative study of two encapsulated streptococci: the capsular polysaccharide differently modulates bacterial interactions with dendritic cells. In Proceedings of the XVIII Lancefield International Symposium, Palermo, Italy, 2011. Abstr. p. 220.
77. Severi, E., Hood, D.W., and Thomas, G.H. 2007. Sialic acid utilization by bacterial pathogens. Microbiology, 153(9): 2817-2822. doi:10.1099/mic.0.2007/009480-0. PMID:17768226.
78. Shi, W.-X., Chammas, R., Varki, N.M., Powell, L., and Varki, A. 1996. Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to I-type lectins, and tissue homing. J. Biol. Chem. 271(49): 31526-31532. doi:10.1074/jbc. 271.49.31526. PMID:8940168.
79. Sjoberg, E.R., Powell, L.D., Klein, A., and Varki, A. 1994. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids. J. Cell Biol. 126(2): 549-562. doi:10.1083/jcb.126.2.549. PMID:8034751.
80. Slotved, H.C., Kong, F., Lambertsen, L., Sauer, S., and Gilbert, G.L. 2007. Serotype IX, a proposed new Streptococcus agalactiae serotype. J. Clin. Microbiol. 45(9): 2929-2936. doi:10.1128/JCM. 00117-07. PMID:17634306.
81. Smith, C.L., Baker, C.J., Anderson, D.C., and Edwards, M.S. 1990. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. J. Infect. Dis. 162 (2): 489-495. doi:10.1093/infdis/162.2.489. PMID:2197341.
82. Smith, H.E., Damman, M., van der Velde, J., Wagenaar, F., Wisselink, H.J., Stockhofe-Zurwieden, N., and Smits, M.A. 1999. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 67(4): 1750-1756. PMID:10085014.
83. Smith, H.E., de Vries, R., van't Slot, R., and Smits, M.A. 2000. The cps locus of Streptococcus suis serotype 2: genetic determinant for the synthesis of sialic acid. Microb. Pathog. 29(2): 127-134. doi:10.1006/mpat.2000.0372. PMID:10906268.
84. Song, L., Zhou, H., Cai, X., Li, C., Liang, J., and Jin, C. 2011. NeuA O-acetylesterase activity is specific for CMP-activated O-acetyl sialic acid in Streptococcus suis serotype 2. Biochem. Biophys. Res. Commun. 410(2): 212-217. doi:10.1016/j.bbrc.2011.05.092. PMID:21624352.
85. Takahashi, S., Aoyagi, Y., Adderson, E.E., Okuwaki, Y., and Bohnsack, J.F. 1999. Capsular sialic acid limits C5a production on type III group B streptococci. Infect. Immun. 67(4): 1866-1870. PMID:10085029.
86. Traore, M.Y., Valentin-Weigand, P., Chhatwal, G.S., and Blobel, H. 1991. Inhibitory effects of fibrinogen on phagocytic killing of streptococcal isolates from humans, cattle and horses. Vet. Microbiol. 28(3): 295-302. doi:10.1016/0378-1135(91)90084-S. PMID:1897132.
87. Valentin-Weigand, P., Benkel, P., Rohde, M., and Chhatwal, G.S. 1996. Entry and intracellular survival of group B streptococci in J774 macrophages. Infect. Immun. 64(7): 2467-2473. PMID: 8698468.
88. Van Calsteren, M.R., Gagnon, F., Lacouture, S., Fittipaldi, N., and Gottschalk, M. 2010. Structure determination of Streptococcus suis serotype 2 capsular polysaccharide. Biochem. Cell Biol. 88 (3): 513-525. doi:10.1139/O09-170. PMID:20555393.
89. Vieira, F.S., Correa, G., Einicker-Lamas, M., and Coutinho-Silva, R. 2010. Host-cell lipid rafts: A safe door for micro-organisms? Biol. Cell, 102(7): 391-407. doi:10.1042/BC20090138. PMID: 20377525.
90. von Delwig, A., Bailey, E., Gibbs, D.M., and Robinson, J.H. 2002. The route of bacterial uptake by macrophages influences the repertoire of epitopes presented to CD4 T cells. Eur. J. Immunol. 32(12): 3714-3719. doi:10.1002/1521-4141(200212) 32:12<3714::AID-IMMU3714>3.0.CO;2-Y. PMID:12516565.
91. Wang, M., and Hajishengallis, G. 2008. Lipid raft-dependent uptake, signalling and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell. Microbiol. 10(10): 2029-2042. doi:10. 1111/j.1462-5822.2008.01185.x. PMID:18547335.
92. Wang, Q.Q., Li, H., Oliver, T., Glogauer, M., Guo, J., and He, Y.W. 2008. Integrin beta 1 regulates phagosome maturation in macrophages through Rac expression. J. Immunol. 180(4): 2419-2428. PMID:18250451.
93. Weiman, S., Dahesh, S., Carlin, A.F., Varki, A., Nizet, V., and Lewis, A.L. 2009. Genetic and biochemical modulation of sialic acid Oacetylation on group B Streptococcus: phenotypic and functional impact. Glycobiology, 19(11): 1204-1213. doi:10.1093/glycob/ cwp111. PMID:19643844.
94. Weiman, S., Uchiyama, S., Lin, F.Y., Chaffin, D., Varki, A., Nizet, V., and Lewis, A.L. 2010. O-acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence. Biochem. J. 428(2): 163-168. doi:10.1042/BJ20100232. PMID: 20334627.
95. Weintraub, A. 2003. Immunology of bacterial polysaccharide antigens. Carbohydr. Res. 338(23): 2539-2547. doi:10.1016/j. carres.2003.07.008. PMID:14670715.
96. Wessels, M.R., Rubens, C.E., Benedi, V.J., and Kasper, D.L. 1989. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc. Natl. Acad. Sci. U.S.A. 86(22): 8983-8987. doi:10.1073/pnas.86.22.8983. PMID:2554337.
97. Wessels, M.R., Haft, R.F., Heggen, L.M., and Rubens, C.E. 1992. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect. Immun. 60(2): 392-400. PMID:1309720.
98. Wessels, M.R., Butko, P., Ma, M., Warren, H.B., Lage, A.L., and Carroll, M.C. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U.S.A. 92(25): 11490-11494.doi:10.1073/pnas.92.25.11490. PMID:8524789.
99. Williams, A.E., and Blakemore, W.F. 1990. Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 162(2): 474-481. doi:10.1093/infdis/162.2.474. PMID:2373874.
100. Ye, C., Zhu, X., Jing, H., Du, H., Segura, M., Zheng, H., et al. 2006. Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg. Infect. Dis. 12(8): 1203-1208. doi:10.3201/eid1708. 060232. PMID:16965698.
101. Yoshizaki, F., Nakayama, H., Iwahara, C., Takamori, K., Ogawa, H., and Iwabuchi, K. 2008. Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. Biochim. Biophys. Acta, 1780(3): 383-392. doi:10.1016/j.bbagen.2007.11.004. PMID:18078821.
102. Yu, H., Jing, H., Chen, Z., Zheng, H., Zhu, X., Wang, H., et al. Streptococcus suis study groups. 2006. Human Streptococcus suis outbreak, Sichuan, China. Emerg. Infect. Dis. 12(6): 914-920.doi:10.3201/eid1206.051194. PMID:16707046.
103. Zheng, H., Luo, X., Segura, M., Sun, H., Ye, C., Gottschalk, M., and Xu, J. 2011. The role of toll-like receptors in the pathogenesis of Streptococcus suis. Vet. Microbiol., In press. doi:10.1016/j.vetmic.2011.10.014. PMID:22055206.